Feb 22 (Reuters) - Qantas Airways Ltd (QAN) :
- SEEING STRONG TRAVEL DEMAND ACROSS PORTFOLIO
- FY24 FUEL COST EXPECTED TO BE A$5.4 BILLION AT CURRENT FUEL PRICES, INCLUSIVE OF HEDGING.
- FY24 NET CAPITAL EXPENDITURE IS EXPECTED TO BE $A3.0-3.2 BILLION
- CAPITAL EXPENDITURE RISING IN FY25 TO BETWEEN A$3.7-3.9 BILLION
- NET DEBT EXPECTED TO BE AT OR BELOW MIDDLE OF TARGET RANGE BY END OF FY24.
- A FURTHER 14 AIRCRAFT ARE EXPECTED TO ARRIVE DURING 2H24
- FY24 DEPRECIATION AND AMORTISATION EXPECTED TO BE $A1.8 BILLION.
- TARGETING TRANSFORMATION INITIATIVES OF APPROXIMATELY A$400 MILLION IN FY24 TO OFFSET IMPACT OF CPI.
- MANUFACTURING DELAYS HAVE IMPACTED DELIVERY DATES FOR FIRST A321XLR FOR QANTAS DOMESTIC BY THREE MONTHS TO EARLY-2025
- UNIT REVENUE IS EXPECTED TO REMAIN STABLE FOR DOMESTIC AND CONTINUE TO NORMALISE FOR INTERNATIONAL IN FY24
- QANTAS LOYALTY TARGETS A$800 MILLION-A$1 BILLION UNDERLYING EBIT BY FY30
- MANUFACTURING DELAYS IMPACTED DELIVERY DATES FOR A350 FOR QANTAS INTERNATIONAL (AND PROJECT SUNRISE) BY SIX MONTHS TO MID-2026.
- NET DEBT ROSE TO A$4.0 BILLION AT END OF DECEMBER 2023
- TOOK DELIVERY OF EIGHT NEW AND MID-LIFE AIRCRAFT DURING 1H24 AS ITS FLEET RENEWAL PROGRAM RAMPS UP
- FOUR ADDITIONAL MID-LIFE A319S HAVE BEEN PURCHASED FOR NETWORK AVIATION
- 8 ADDITIONAL A321XLRS ON ORDER FOR QANTAS DOMESTIC
- TRAVEL DEMAND REMAINS STRONG ACROSS ALL SECTORS, WITH LEISURE CONTINUING TO LEAD AND BUSINESS TRAVEL NOW APPROACHING PRE-COVID LEVELS
- Forums
- ASX - By Stock
- QAN
- News: QAN Qantas Sees Strong Travel Demand Across Portfolio
News: QAN Qantas Sees Strong Travel Demand Across Portfolio
Featured News
Add QAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.90 |
Change
0.020(0.34%) |
Mkt cap ! $9.613B |
Open | High | Low | Value | Volume |
$5.89 | $5.91 | $5.82 | $24.42M | 4.149M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | $5.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.90 | 20864 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 36366 | 5.870 |
3 | 35001 | 5.860 |
3 | 88840 | 5.850 |
2 | 63562 | 5.840 |
2 | 25953 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
5.900 | 20864 | 2 |
5.910 | 66749 | 10 |
5.920 | 108198 | 18 |
5.930 | 72440 | 15 |
5.940 | 43717 | 14 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$5.88 |
  |
Change
0.020 ( 0.19 %) |
|||
Open | High | Low | Volume | ||
$5.89 | $5.91 | $5.82 | 1773655 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
QAN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online